Financial Performance - The company's operating revenue for the third quarter reached ¥351,584,503.91, representing a year-on-year increase of 25.94%[4] - The total profit for the third quarter was ¥58,722,638.31, reflecting a significant increase of 53.98% compared to the same period last year[4] - The net profit attributable to shareholders for the third quarter was ¥46,327,956.87, up 44.71% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥43,295,471.69, showing a substantial increase of 79.40% compared to the previous year[4] - Total operating revenue for the first three quarters of 2025 reached ¥979,111,093.03, a 20.7% increase from ¥811,377,889.62 in the same period of 2024[22] - Net profit for the first three quarters of 2025 was ¥119,734,016.41, representing a 42.8% increase compared to ¥83,853,892.80 in the previous year[23] - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥1.37, up from ¥0.94 in the same period of 2024[24] - The basic earnings per share for the third quarter were ¥0.54, reflecting an increase of 54.29% compared to the same period last year[5] - The company reported a total comprehensive income of ¥121,680,002.04 for the first three quarters of 2025, compared to ¥87,226,599.54 in the previous year[24] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥2,562,961,700.00, an increase of 5.99% from the end of the previous year[5] - As of September 30, 2025, the total assets of the company amounted to RMB 2,562,961,700, an increase from RMB 2,418,035,118.40 as of December 31, 2024, representing a growth of approximately 5.95%[16] - Total liabilities increased to ¥560,499,333.57, compared to ¥390,912,654.76 in the previous year, reflecting a significant rise in financial obligations[18] - Total equity attributable to shareholders decreased to ¥2,002,462,366.43 from ¥2,027,122,463.64 year-over-year[19] - The company's total current assets reached RMB 2,369,501,774.04, compared to RMB 2,208,723,169.25, which is an increase of about 7.29%[17] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥8,732,704.38, which decreased by 91.32% year-on-year[4] - Cash flow from operating activities for the first three quarters of 2025 was ¥929,154,255.85, compared to ¥826,956,332.59 in the same period of 2024[25] - Operating cash inflow totaled $997,205,055.86, an increase of 12.1% from $889,986,877.02[26] - Operating cash outflow amounted to $988,472,351.48, up from $789,436,921.65, resulting in a net cash flow from operating activities of $8,732,704.38, down 91.3% from $100,549,955.37[26] - Cash inflow from investment activities reached $3,368,193,225.84, significantly higher than $360,254,145.57, while cash outflow was $3,486,621,789.06, leading to a net cash flow from investment activities of -$118,428,563.22[26] - Cash inflow from financing activities was $279,935,276.04, compared to $112,168,202.17, while cash outflow totaled $309,855,510.11, resulting in a net cash flow from financing activities of -$29,920,234.07[27] - The net increase in cash and cash equivalents was -$142,884,310.18, compared to -$386,156,614.74 in the previous period[27] - The ending balance of cash and cash equivalents stood at $953,736,388.07, up from $878,913,439.70[27] Shareholder Information - The company reported a total of 3,493 common shareholders at the end of the reporting period[12] - The company has a shareholding structure with significant stakes held by various investment partnerships, including 5,019,806 shares held by Zhoushan Xinxin Enterprise Management Partnership[14] - The company has a total of 4,730,172 shares repurchased, representing 5.20% of its total shares, which may indicate a strategy to enhance shareholder value[14] - The company has not reported any significant changes in the participation of major shareholders in margin financing or securities lending activities[14] Research and Development - Research and development expenses totaled ¥16,038,057.40 for the quarter, accounting for 4.56% of operating revenue, a decrease of 0.98 percentage points year-on-year[5] - Research and development expenses for the first three quarters of 2025 were ¥46,034,736.98, slightly up from ¥45,523,716.19 in the previous year[22] Financial Statements and Accounting - The company’s financial statements for the reporting period are unaudited, indicating a need for caution in interpreting the financial data[15] - The company will implement new accounting standards starting in 2025, which may affect the financial statements[28] Other Financial Metrics - Financial expenses recorded a loss of ¥7,098,512.41, contrasting with a gain of ¥5,325,990.16 in the same period of 2024[23] - The company received tax refunds of $40,429,228.34, compared to $37,423,828.32 in the previous period[26] - The company paid $134,615,488.48 in employee compensation, an increase from $127,648,964.92[26] - The company reported a decrease in tax payments to $38,142,548.69 from $53,293,563.62[26]

Financial Performance - The company's operating revenue for Q3 2025 was ¥129,276,765.58, a decrease of 20.19% compared to the same period last year[5] - Total profit for the quarter was ¥23,353,885.74, reflecting an increase of 17.94% year-over-year[5] - Net profit attributable to shareholders was ¥19,839,825.68, up 14.14% from the previous year[5] - The net profit after deducting non-recurring gains and losses was ¥8,877,250.79, down 22.27% year-to-date[5] - The company's operating revenue for the current period is ¥450,632,220.32, a decrease of 19.0% compared to ¥556,662,012.29 in the previous period[20] - Net profit for the current period is ¥79,603,107.31, down 19.5% from ¥98,928,917.49 in the previous period[20] - The company’s total profit before tax is ¥91,671,643.98, a decrease of 20.2% from ¥114,947,969.55 in the previous period[20] - Operating profit for the first three quarters of 2025 was ¥92.81 million, down 21.73% from ¥118.51 million in 2024[31] - Net profit for the first three quarters of 2025 was ¥81.43 million, a decline of 21.73% compared to ¥104.06 million in 2024[31] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was ¥31,246,803.14, a significant decrease of 78.04%[5][10] - Cash flow from operating activities generated a net amount of ¥31,246,803.14, a significant decrease of 78.1% from ¥142,302,212.58 in the previous period[23] - Cash and cash equivalents at the end of Q3 2025 stand at CNY 75,932,854.60, down from CNY 220,898,933.75 at the end of Q3 2024[34] - The company experienced a net decrease in cash and cash equivalents of CNY 138,991,629.63 in 2025, compared to a decrease of CNY 47,451,217.60 in 2024[34] - Total cash outflow from operating activities decreased to CNY 283,863,464.85 in 2025 from CNY 307,841,395.22 in 2024, a reduction of 7.8%[33] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,386,663,342.38, down 6.25% from the previous year[6] - Current assets as of September 30, 2025, totaled RMB 1,872,890,467.95, down from RMB 1,938,692,381.54 at the end of 2024[15] - Total liabilities amounted to RMB 185,023,051.59, a decrease from RMB 251,604,573.85 in the previous year[17] - Non-current assets were valued at RMB 513,772,874.43, down from RMB 607,198,125.32 at the end of 2024[16] - Total equity attributable to shareholders was RMB 2,171,533,508.24, down from RMB 2,264,929,554.10 in the previous year[17] - The company's total equity as of September 30, 2025, was ¥2.19 billion, a decrease of 3.99% from ¥2.28 billion at the end of 2024[28] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 20,046[12] - The largest shareholder, Chi Lin, holds 45.99% of the shares, totaling 145,215,265 shares[12] Operational Efficiency - The company reported a significant decline in gross profit margin, primarily due to decreased product margins[10] - Total operating costs decreased to ¥391,829,902.97 from ¥464,130,138.28, reflecting a reduction of 15.6%[20] - Basic and diluted earnings per share are both ¥0.25, compared to ¥0.31 in the previous period[21] - Research and development expenses for the first three quarters of 2025 were ¥16.49 million, a decrease of 14.38% from ¥19.24 million in 2024[31] Investment Activities - Cash flow from investment activities resulted in a net inflow of ¥49,654,679.28, contrasting with a net outflow of ¥179,343,801.18 in the previous period[24] - The company did not report any cash inflow from new investments or acquisitions during the first three quarters of 2025[34] - Total cash inflow from investment activities decreased to CNY 1,420,595,697.46 in 2025 from CNY 2,755,233,379.25 in 2024, representing a decline of 48.3%[34] Market and Product Development - The company has not disclosed any new product developments or market expansion strategies during the reporting period[14]

Financial Performance - The company's operating revenue for the third quarter reached ¥284,292,182.46, representing a year-on-year increase of 69.39%[4] - The total profit for the period was ¥33,911,516.03, reflecting a growth of 22.32% compared to the same period last year[4] - The net profit attributable to shareholders was ¥34,300,134.11, which is an increase of 34.56% year-on-year[4] - The basic earnings per share for the quarter was ¥0.28, up by 33.33% from the previous year[4] - Total operating revenue for the first three quarters of 2025 reached ¥605,385,587.16, a significant increase of 41.5% compared to ¥427,887,891.05 in the same period of 2024[16] - Net profit for the first three quarters of 2025 was ¥52,494,629.86, representing a 29.7% increase from ¥40,477,868.59 in 2024[17] - The company's operating profit for the first three quarters of 2025 was ¥51,589,859.11, compared to ¥37,721,298.01 in 2024, reflecting a growth of 37.0%[16] - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.43, up from ¥0.33 in 2024[17] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,334,125,072.61, a 4.18% increase from the end of the previous year[5] - The equity attributable to shareholders increased to ¥929,492,640.76, marking a 3.66% rise compared to the previous year[5] - The company's total liabilities increased to ¥1,404,566,320.32 in 2025 from ¥1,343,959,580.55 in 2024, indicating a rise of 4.5%[14] - Total equity attributable to shareholders reached ¥929,492,640.76 in 2025, compared to ¥896,641,102.42 in 2024, marking an increase of 3.7%[14] Cash Flow - The cash flow from operating activities showed a net outflow of ¥95,685,405.08 for the year-to-date period[4] - The net cash flow from operating activities for the first three quarters of 2025 was -¥95,685,405.08, an improvement from -¥157,367,281.88 in 2024[18] - The company experienced a net decrease in cash and cash equivalents of $111,570,689.22, compared to a decrease of $226,129,581.39 in the prior period[19] Current Assets and Inventory - As of September 30, 2025, the company's total current assets amounted to RMB 1,787.92 million, an increase from RMB 1,685.58 million at the end of 2024[13] - Accounts receivable increased to RMB 193.84 million from RMB 149.70 million, reflecting a growth of approximately 29.5%[12] - Inventory rose to RMB 1,218.27 million, up from RMB 1,072.07 million, indicating a growth of about 13.6%[12] Government Support and Expenses - Government subsidies and reduced credit impairment losses contributed positively to the profit growth during the reporting period[8] - Research and development expenses for the first three quarters of 2025 were ¥37,056,064.94, a decrease of 14.2% from ¥43,187,204.84 in 2024[16] - The company reported other income of ¥18,469,316.64 for the first three quarters of 2025, significantly higher than ¥6,728,612.57 in 2024, reflecting a growth of 174.5%[16] Customer Guarantees and Liabilities - The company provided guarantees for cotton picker customers' mortgage loans totaling RMB 336.99 million, accounting for 37.58% of the latest audited net assets[11] - The company compensated RMB 9.59 million for part of the cotton picker mortgage loans during the reporting period, with an estimated liability provision of RMB 14.40 million[11] - The company reported a total liability of RMB 613.97 million in contract liabilities, up from RMB 593.09 million[13] Cash Management - The company's cash and cash equivalents decreased to RMB 239.15 million from RMB 349.96 million[12] - Cash used for the acquisition of fixed assets, intangible assets, and other long-term assets was $13,654,619.97, down from $18,663,271.62[19] - Cash paid for debt repayment was $65,000,000, compared to $29,900,000 in the previous period[19] Accounting Standards - The company did not apply new accounting standards starting from 2025[20]

Financial Performance - The company's operating revenue for the third quarter was ¥3,829,411,071.58, a decrease of 13.18% compared to the same period last year[4] - The total profit for the third quarter was ¥219,779,678.61, down 37.93% year-on-year[4] - The net profit attributable to shareholders was ¥191,846,385.55, reflecting a decline of 41.79% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥181,219,858.10, a decrease of 43.23% year-on-year[4] - The basic earnings per share for the third quarter was ¥0.07, down 41.67% from the same period last year[4] - The diluted earnings per share was ¥0.08, a decrease of 38.46% year-on-year[4] - The net profit for the year-to-date period was ¥687,598,094.54, down 45.34% compared to the same period last year[4] - Total operating revenue for the first three quarters of 2025 was CNY 11,787,924,723.01, a decrease of 22.5% compared to CNY 15,174,251,391.12 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 667,831,464.19, a decline of 46.5% compared to CNY 1,256,863,367.93 in 2024[19] - Earnings per share for the first three quarters of 2025 were CNY 0.26, down from CNY 0.48 in the same period of 2024[20] - The total comprehensive income for the first three quarters of 2025 was CNY 661,137,257.84, down from CNY 1,287,299,247.51 in 2024[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥20,684,415,747.11, a decrease of 2.49% from the end of the previous year[5] - As of September 30, 2025, the total assets amounted to RMB 20,684,415,747.11, a decrease from RMB 21,211,809,320.40 as of December 31, 2024, reflecting a decline of approximately 2.48%[14] - Current assets totaled RMB 15,280,973,315.34, down from RMB 15,925,575,984.71, indicating a decrease of about 4.05%[15] - The company's fixed assets rose to RMB 4,176,960,147.15 from RMB 3,886,744,435.08, reflecting an increase of approximately 7.45%[15] - The total liabilities decreased to CNY 4,083,409,225.81 in 2025 from CNY 4,594,141,839.45 in 2024, reflecting a reduction of 11.1%[17] - The total liabilities were not explicitly stated, but current liabilities included accounts payable of RMB 809,656,434.24, down from RMB 925,268,505.83, indicating a decrease of about 12.50%[15] - The company reported a total of RMB 5,403,442,431.77 in non-current assets, an increase from RMB 5,286,233,335.69, representing a growth of approximately 2.22%[15] Cash Flow - The company reported a significant decline in cash flow from operating activities, with a net cash flow of ¥13,947,307.42, down 99.50% year-on-year[4] - In the first three quarters of 2025, the cash inflow from operating activities was approximately CNY 10.98 billion, a decrease of 27.5% compared to CNY 15.11 billion in the same period of 2024[21] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 13.95 million, significantly lower than CNY 2.79 billion in 2024[22] - The total cash outflow from investing activities in the first three quarters of 2025 was CNY 14.51 billion, compared to CNY 4.98 billion in 2024, resulting in a net cash outflow of CNY 1.63 billion[22] - Cash inflow from investment activities was CNY 12.88 billion in 2025, a substantial increase from CNY 2.27 billion in 2024[22] - The cash outflow for financing activities in the first three quarters of 2025 was CNY 1.06 billion, compared to CNY 1.65 billion in 2024, leading to a net cash outflow of CNY 1.05 billion[22] - The cash and cash equivalents at the end of the third quarter of 2025 were CNY 2.34 billion, down from CNY 4.59 billion at the end of the same period in 2024[22] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 363,965,846.53, a decrease of 29.7% from CNY 518,013,725.90 in 2024[18] Shareholder Information - There were no significant changes in the top 10 shareholders or their shareholding percentages compared to the previous period[13] Company Activities - The company has not disclosed any new product developments or market expansion strategies during the reporting period[13] - The company did not participate in any financing or securities lending activities during the reporting period[13]

南京诺唯赞生物科技股份有限公司 2025 年第三季度报告 证券代码：688105 证券简称：诺唯赞 南京诺唯赞生物科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 | | | 本报告期比 | | 年初至报告 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 期末比上年 | | | | 减变动幅度 | | 同期增减变 | | | | (%) | | 动幅度(%) | | 营业收入 | 346,183,744.66 | 2.84 | 952,404,074.47 | -3.40 | | 利润总额 | -6,902,600.10 | 不适 ...

Revenue and Profitability - Revenue for Q3 2025 was CNY 87,708,575.06, a decrease of 15.68% compared to the same period last year[3] - Year-to-date revenue reached CNY 222,912,349.82, down 38.13% year-over-year[3] - Net profit attributable to shareholders for Q3 2025 was CNY 5,942,355.49, with a year-to-date net profit of CNY 34,269,812.83[3] - Basic earnings per share for Q3 2025 was CNY 0.02, unchanged from the previous period[4] - The company reported a net loss of CNY 204,554,988.59 for the first three quarters of 2025, an improvement from a net loss of CNY 238,824,801.42 in the same period of 2024[13] - The net profit for the first three quarters of 2025 is CNY 36,097,511.29, a significant recovery from a net loss of CNY -166,251,751.36 in the same period of 2024[15] - Operating profit for the current period is CNY 38,512,946.55, compared to a loss of CNY -159,160,870.71 in the previous year[15] - The total comprehensive income for the current period is CNY 36,097,511.29, compared to a total comprehensive loss of CNY -166,251,751.36 in the same period last year[16] Cash Flow and Liquidity - The company reported a significant improvement in cash flow from operating activities, with a net cash flow of CNY 12,812,043.23 year-to-date[3] - Cash flow from operating activities shows a net inflow of CNY 12,812,043.23, improving from a net outflow of CNY -45,585,403.83 in the prior year[17] - Cash flow from investing activities has a net inflow of CNY 225,523,580.03, recovering from a net outflow of CNY -72,306,847.78 in the same period last year[18] - Total cash and cash equivalents at the end of the period stand at CNY 239,632,571.26, up from CNY 144,121,483.02 at the end of the previous year[18] - Cash and cash equivalents increased to CNY 252,445,201.14 as of September 30, 2025, compared to CNY 119,336,851.27 at the end of 2024, representing a growth of 111.4%[11] - The company has reported a decrease in cash received from tax refunds to CNY 7,866,080.63 from CNY 151,795,357.26 in the previous year[17] Assets and Liabilities - Total assets decreased by 60.55% to CNY 1,248,366,147.81 compared to the end of the previous year[4] - Total assets decreased to CNY 1,248,366,147.81 as of September 30, 2025, down from CNY 3,164,052,059.39 at the end of 2024[12] - Total liabilities decreased to CNY 404,569,775.22 as of September 30, 2025, compared to CNY 2,359,264,396.45 at the end of 2024[12] - The company’s total equity increased to CNY 843,796,372.59 as of September 30, 2025, compared to CNY 804,787,662.94 at the end of 2024[13] Shareholder Information - Shareholders' equity attributable to the parent company increased by 4.27% to CNY 833,813,770.16[4] - The total number of ordinary shareholders at the end of the reporting period was 38,943[9] Operational Performance - The disposal of the photovoltaic business in January 2025 led to a reduction in operational losses and a return to profitability in the medical sector[7] - Total operating revenue for the first three quarters of 2025 was CNY 222,912,349.82, a decrease of 38.1% compared to CNY 360,301,548.27 in the same period of 2024[14] - Total operating costs for the first three quarters of 2025 were CNY 211,917,664.40, down 63.4% from CNY 579,593,276.48 in the previous year[14] - Research and development expenses for the first three quarters of 2025 amounted to CNY 21,794,272.31, a reduction of 49.7% compared to CNY 43,316,194.03 in 2024[14] Investment Performance - The company’s long-term equity investments were valued at CNY 15,039,043.87 as of September 30, 2025, down from CNY 15,942,052.41 at the end of 2024[11] - The company has received CNY 390,000,000.00 from the recovery of investments, compared to CNY 469,000,000.00 in the same period last year[18]

Financial Performance - The company's revenue for Q3 2025 was CNY 466,315,308.43, representing a 9.80% increase year-over-year[5] - Net profit attributable to shareholders decreased by 7.10% to CNY 25,207,354.41 for the same period[5] - The net profit after deducting non-recurring gains and losses was CNY 23,789,540.75, down 12.73% year-over-year[5] - Total operating revenue for the current period reached ¥1,355,645,119.71, an increase of 8.1% compared to ¥1,254,037,408.51 in the previous period[19] - Net profit for the current period was ¥119,451,627.92, representing a 9.3% increase from ¥109,643,066.89 in the previous period[20] - Total comprehensive income for the period reached CNY 116,797,170.62, an increase from CNY 107,145,756.59 in the previous period, representing a growth of approximately 6.14%[21] - Basic earnings per share increased to 0.1672 from 0.1486, reflecting a growth of about 11.6% year-over-year[21] Assets and Liabilities - Total assets increased by 8.87% to CNY 3,218,656,694.43 compared to the end of the previous year[5] - The company's total assets increased to ¥3,218,656,694.43, compared to ¥2,956,338,872.28, marking a growth of 8.9%[18] - Current liabilities rose to ¥1,316,394,100.83, up from ¥1,103,726,755.46, indicating a 19.3% increase[18] - The total liabilities decreased to ¥1,670,078,518.00 from ¥1,645,242,044.47, a slight reduction of 1.5%[18] - Long-term borrowings slightly increased to ¥65,686,587.70 from ¥65,511,233.27, showing a marginal rise of 0.3%[18] Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 196,449,677.83, a decrease of 7.69%[5] - Cash flow from operating activities generated a net amount of CNY 196,449,677.83, down from CNY 212,819,194.37, indicating a decrease of approximately 7.7%[23] - Total cash outflow from operating activities was CNY 1,247,662,172.11, compared to CNY 1,116,181,306.02 in the previous period, indicating an increase of approximately 11.8%[23] - Cash inflow from investment activities totaled CNY 547,313,560.79, significantly up from CNY 5,959,890.50, marking an increase of over 9,000%[23] - Cash flow from financing activities yielded a net increase of CNY 116,035,296.68, compared to a net outflow of CNY 113,083,615.29 in the previous period[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,993[13] - The largest shareholder, Qu Jianguo, holds 31.83% of shares, totaling 194,638,209 shares, with 145,978,657 shares pledged[13] - The total number of restricted shares held by Qu Jianguo is 145,978,657, which are subject to a lock-up period[15] - The total number of shares held by the top 10 unrestricted shareholders is 146,997,457[15] - There are no significant changes in the top 10 shareholders due to securities lending or borrowing[14] Financial Expenses and Investments - Financial expenses rose by 49.08% to CNY 16,794,628.06, primarily due to a decrease in foreign exchange gains[9] - The company reported a decrease in financial expenses to ¥16,794,628.06 from ¥11,265,300.04, a rise of 49.4%[20] - Investment activities generated a net cash inflow of CNY 63,159,837.33, a 210.45% increase compared to the previous period[10] Research and Development - Research and development expenses for the current period were ¥47,792,071.38, compared to ¥46,343,257.83, an increase of 3.1%[20] Strategic Developments - The company did not report any new strategies or product developments during the conference call[1] - The company has not disclosed any plans for market expansion or mergers and acquisitions in the call[14] - The company has no new products or technologies mentioned in the conference call[14] - The company has not yet audited its third-quarter financial report[25]

Revenue and Profitability - The company's revenue for Q3 2025 reached ¥182,821,527.07, representing a 47.60% increase year-over-year[4] - Net profit attributable to shareholders was ¥12,480,179.22, a significant increase of 238.16% compared to the same period last year[4] - The basic earnings per share (EPS) was ¥0.0491, up 238.31% from ¥0.0022 in the previous year[4] - Total operating revenue for the current period reached ¥446,700,660.13, an increase of 22.2% compared to ¥365,513,595.46 in the previous period[21] - The company achieved sales of goods and services amounting to 482,962,827.39, compared to 391,768,092.02 in the previous year, indicating a positive sales trend[24] - The total comprehensive income for the period was -1,570,958.07, compared to 4,471,779.92 in the previous year, indicating a significant drop in overall financial health[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,767,635,936.78, reflecting a 3.09% increase from the end of the previous year[4] - The company's total liabilities increased to ¥728,373,713.99 from ¥665,928,204.49, a rise of 9.4%[19] - The total equity attributable to shareholders decreased to ¥1,037,517,280.24 from ¥1,044,907,151.11, a decline of 0.7%[19] - Long-term borrowings significantly increased to ¥115,561,538.00 from ¥38,590,006.83, marking a rise of 199.5%[19] - The company's cash and cash equivalents decreased to ¥168,292,571.97 from ¥180,455,071.07, reflecting a decline of 6.5%[17] Cash Flow - The company reported a net cash flow from operating activities of -¥12,382,468.06, a decrease of 92.49% compared to the previous year[4] - Cash flow from operating activities improved significantly, with a net cash flow of -12,382,468.06 yuan, an increase of 92.49% compared to the previous period[10] - The net cash flow from operating activities was -12,382,468.06, an improvement from -164,783,422.79 in the previous year, indicating better cash management[25] - Cash inflow from investment activities decreased by 58.43% to 376,380.68 yuan, mainly due to a reduction in the disposal of fixed assets[10] - Cash outflow from financing activities increased by 32.79% to 276,973,879.94 yuan, primarily due to increased bank loan repayments[10] Expenses and Costs - Total operating costs amounted to ¥458,241,622.89, up 19.7% from ¥383,083,419.29 in the prior period[21] - Financial expenses increased by 79.28% to ¥7,725,537.92, primarily due to higher bank loan interest expenses[9] - The company incurred financial expenses of 7,725,537.92, up from 4,309,083.26, primarily due to increased interest expenses[22] - Research and development expenses rose to 55,846,076.33, compared to 50,097,675.89, highlighting the company's commitment to innovation[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,333[12] - The largest shareholder, Zhao Zi'an, holds 35.33% of the shares, totaling 89,817,478 shares[12] - The company had a total of 75,076,318 restricted shares at the beginning of the period, with 469,300 shares released from restrictions during the period[15] Other Income and Gains - The company recorded a 6862.46% increase in other income, amounting to ¥591,266.86, attributed to debt restructuring gains and compensation received[9] - Tax refunds received decreased by 80.68% to 2,601,205.93 yuan, mainly due to a reduction in government subsidies[10] - The company distributed dividends totaling 18,974,727.69 yuan, a decrease of 65.17% year-over-year[10]

Financial Performance - The company's operating revenue for the third quarter reached ¥128,070,909.72, an increase of 44.68% compared to the same period last year[4] - The total profit for the quarter was -¥16,222,984.50, reflecting a decrease of 52.24% year-on-year[9] - The net profit attributable to shareholders was -¥15,635,515.80, a decline of 50.63% compared to the previous year[9] - Basic earnings per share for the quarter were -¥0.031, down 50.49% from the same period last year[5] - The net loss for the first three quarters of 2025 was CNY 32,079,595.49, worsening from a net loss of CNY 28,408,106.70 in the same period of 2024[25] - The total comprehensive income attributable to the parent company was -38,414,804.78 CNY, compared to -40,981,431.23 CNY in the previous year, indicating a slight improvement[26] - The company’s basic and diluted earnings per share were both -0.0629 CNY, compared to -0.0547 CNY in the previous year[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥514,119,492.71, representing a 20.93% increase from the end of the previous year[5] - The company's total assets as of the reporting date amounted to CNY 514,119,492.71, up from CNY 425,130,680.55 in the previous year[21] - Total liabilities increased to CNY 433,703,215.73 from CNY 332,980,043.52, reflecting a rise of approximately 30.2%[21] - Current assets totaled CNY 383,609,692.93, compared to CNY 284,607,893.56 in the previous year, marking a growth of about 34.7%[20] - The total equity attributable to shareholders decreased to CNY 73,278,731.68 from CNY 84,692,180.24, a decline of about 13.3%[21] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥82,608,078.80, indicating a significant cash outflow[4] - The net cash flow from operating activities for the first three quarters of 2025 was -82,608,078.80 CNY, a significant decline from -5,446,601.00 CNY in the same period of 2024[28] - Cash inflow from operating activities totaled 405,168,386.75 CNY, down from 520,201,051.84 CNY year-over-year[29] - The company reported a net cash flow from investing activities of 50,214,687.96 CNY, a recovery from a negative cash flow of -2,287,205.85 CNY in the previous year[30] - Cash flow from financing activities generated a net inflow of 63,021,148.74 CNY, compared to a net outflow of -15,244,804.43 CNY in the same period last year[30] - The cash outflow for operating activities was 487,776,465.55 CNY, compared to 525,647,652.84 CNY in the same period last year[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,395[11] - Jiangxi Tourism Group holds 98,803,000 shares, accounting for 19.57% of total shares[11] Restructuring and Strategic Initiatives - The company plans to initiate a major asset restructuring involving Runtian Industrial, which specializes in the production and sales of packaged drinking water[13] - The restructuring aims to enhance asset quality, profitability, and sustainable operational capacity[15] - The company incurred additional service fees related to a major asset restructuring project, impacting short-term profit metrics[9] - The company completed the transfer of debt rights valued at RMB 37.24 million to Jiangxi Tourism Group[16] - The company also sold 100% equity of Jiangxi Guogui Cultural Tourism Development Co., Ltd. for RMB 13.60 million[17] Operational Efficiency - The company attributed the revenue growth to the performance of its subsidiaries, particularly in new business lines[9] - The net profit margin has been negatively affected by ongoing operational losses, despite efforts to improve efficiency and reduce costs[9] - The weighted average return on net assets was -24.80%, a decrease of 27.96 percentage points year-on-year[5] - The company incurred financial expenses of CNY 10,990,481.23, up from CNY 9,923,140.90 in the previous year, indicating an increase of approximately 10.8%[25] - Other comprehensive income after tax for the first three quarters of 2025 was a loss of CNY 6,656,120.78, compared to a loss of CNY 13,384,853.56 in the same period of 2024, showing an improvement[25] - The total operating costs for the first three quarters of 2025 were CNY 350,765,630.23, compared to CNY 314,646,173.19 in 2024, indicating an increase of about 11.5%[24]

Financial Performance - The company's revenue for Q3 2025 was approximately ¥273.70 million, representing a decrease of 38.41% compared to the same period last year[4]. - The total profit for the period was a loss of ¥28.43 million, with a net profit attributable to shareholders of ¥31.12 million, indicating significant financial challenges[4]. - For the first nine months of 2025, the company reported a total revenue of ¥857.21 million, down 39.64% year-on-year, with a net loss of ¥87.24 million[6]. - Total revenue for the first three quarters of 2025 was ¥857,205,461.50, a decrease of 39.7% compared to ¥1,420,111,454.42 in the same period of 2024[23]. - Net loss for the first three quarters of 2025 was ¥79,153,203.33, compared to a net loss of ¥33,512,646.83 in 2024, representing a 135.7% increase in losses[24]. - Operating profit for the first three quarters of 2025 was -¥80,483,168.62, worsening from -¥50,183,819.91 in the same period of 2024[24]. - Basic and diluted earnings per share for the first three quarters of 2025 were both -¥0.44, compared to -¥0.28 in 2024[25]. Revenue Decline Factors - The company attributed the revenue decline to the transfer of certain subsidiaries and a strategic shift towards optimizing its business structure[6]. - The company is focusing on transforming its traditional medical supply chain services towards medical intelligence, which has impacted revenue and profit margins[6]. Cash Flow and Expenses - Cash flow from operating activities showed a net inflow of ¥54.57 million, reflecting a decrease in cash received from sales and services[5]. - The company has implemented cost control measures, resulting in a reduction of sales, management, and financial expenses by ¥50 million, or 18.54% year-on-year[7]. - In the first three quarters of 2025, the cash inflow from operating activities was CNY 998,060,771.28, a decrease of 38.0% compared to CNY 1,608,884,916.58 in the same period of 2024[27]. - The net cash flow from operating activities was negative at CNY -24,599,514.16, compared to a positive CNY 496,140.58 in the first three quarters of 2024[27]. - The company reported a total cash outflow from operating activities of CNY 1,022,660,285.44, compared to CNY 1,608,388,776.00 in the previous year[27]. Asset and Equity Changes - The total assets at the end of the reporting period were approximately ¥2.09 billion, a decrease of 26.14% from the previous year[5]. - The equity attributable to shareholders increased by 16.78% to ¥1.09 billion compared to the end of the previous year[5]. - Total assets decreased from ¥2,830,070,456.98 in the previous period to ¥2,090,356,280.83, a decline of 26.2%[21]. - The company's equity increased from ¥962,044,094.58 to ¥1,053,305,930.21, an increase of 9.5%[21]. Current Assets and Liabilities - The company reported a total current assets of RMB 1,381,721,482.71 as of September 30, 2025, a decrease of approximately 33.8% from RMB 2,087,128,419.96 on December 31, 2024[19]. - Cash and cash equivalents decreased to RMB 139,610,238.67 from RMB 209,435,589.90, representing a decline of about 33.3%[19]. - Accounts receivable fell to RMB 834,694,092.99, down 35.3% from RMB 1,288,755,013.77[19]. - Inventory decreased to RMB 217,162,250.62, a drop of approximately 33.4% from RMB 326,159,533.80[19]. - Total liabilities decreased from ¥1,868,026,362.40 to ¥1,037,050,350.62, a reduction of 44.4%[21]. Shareholder Information - The company has a major shareholder, Saihai (Shanghai) Health Technology Co., Ltd., holding 10.30% of shares, with 21,642,540 shares[15]. - Shanghai Anze Private Fund Management Co., Ltd. holds 5.76% of shares, totaling 12,100,399 shares[15]. - The company repurchased 3,977,700 shares, accounting for 1.89% of the total share capital as of September 30, 2025[16]. - The company has not reported any significant changes in the participation of major shareholders in margin trading or securities lending[16]. Investment Activities - The company reported an investment income of ¥7,343,276.69 in the first three quarters of 2025, compared to a loss of -¥47,577,734.26 in the same period of 2024[24]. - The cash inflow from investment activities totaled CNY 61,047,772.08, an increase of 87.0% from CNY 32,619,956.30 in the previous year[28]. - The net cash flow from investment activities was CNY 36,083,836.68, significantly up from CNY 7,540,032.26 in the same period last year[28]. - The company received CNY 19,285,848.50 from other investment-related cash activities, slightly up from CNY 18,239,609.15 in 2024[28].